HHLA2 and lung carcinoma: However, there is currently no research reporting whether LINC00665 can promote the expression of HHLA2 in lung cancer cells and inhibit NK cell cytotoxicity by targeting binding TCF7, leading to immune escape and the development of lung cancer.